Updates are available Correction dated 2022-09-03
Click to view Correction: https://doi.org/10.1007/s40264-022-01233-9
-
Authors
Lane, Samantha http://orcid.org/0000-0001-7532-1149
Shakir, Saad
- License Information
-
More Information
Article History
Accepted: 19 July 2022
First Online: 4 August 2022
Change Date: 3 September 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40264-022-01233-9
Declarations
:
: The Drug Safety Research Unit (DSRU) receives donations and grants from pharmaceutical companies; however, the companies have no control over the conduct or publication of its studies. The DSRU has received grants to conduct unconditional studies on the Oxford/AstraZeneca COVID-19 vaccine and for conducting Clinical Practice Research Datalink (CPRD) studies for Pfizer, Moderna, and Janssen COVID-19 vaccines. The DSRU has conducted benefit–risk studies on products for COVID-19, including remdesivir, lopinavir/ritonavir, chloroquine and hydroxychloroquine, and convalescent plasma. Professor Shakir is the principal investigator for an active surveillance study for the Oxford/AstraZeneca vaccine, but this assessment is unrelated to this study. Professor Shakir has been a member of Data Safety Monitoring Boards for Ipsen, Biogen, and Diurnal. None of these companies have any involvement with COVID-19 vaccines. Professor Shakir was also invited by AstraZeneca to advise on the events of thrombosis with thrombocytopenia with the COVID-19 vaccine and to be a member of an advisory committee on a safety study of the Oxford/AstraZeneca vaccine in Europe. Samantha Lane has no conflicts of interest with regard to this study.
: No external funding was received for the completion of this study.
: No additional data are available.
: Not applicable.
: Patients and the public were not consulted during the course of this study.
: Ethics approval was not required for this research due to the nature of the data source.
: Not applicable.
: Not applicable.
: Samantha Lane was responsible for data acquisition, analyses, and interpretation. Samantha Lane and Saad Shakir were responsible for study conception, drafting and reviewing the manuscript, and approval of the final version for publication.
